The Mount Sinai Stroke Center

Stroke Research

The Mount Sinai Stroke Center is a recognized leader in stroke research. Our research focuses on the prevention of stroke, the treatment of acute stroke and on ways to help patients recover optimally from stroke. We have also explored ways to reduce the risk of recurrent stroke, especially in African-Americans and Latinos.

We are currently involved in the following research:

In conjunction with the Department of Health Evidence and Policy, with funding from the Agency for Healthcare Research and Quality and the National Center on Minority Health and Health Disparities, we have conducted a series of studies to determine the causes of underuse of effective stroke prevention therapies among minority populations. Most recently, we have implemented and evaluated a program to address these causes in patients hospitalized at Mount Sinai, as well as those living in the communities served by Mount Sinai.

In conjunction with the Department of Neurosurgery, we are participating in two federally-funded, international studies to assess the efficacy of thrombolytic (clot-busting) medication to help dissolve blood clots in patients with intracerebral bleeding.

In collaboration with the Division of Neuroradiology, we are examining the application of new CT and MRI techniques to patients with stroke to provide quicker and more accurate diagnostic and prognostic information.

We are embarking on a new cooperative study to determine the safety and efficacy of a new agent to improve recovery after stroke.